The Medicines Co. Prices $150M Private Notes Offering
The Medicines Co. said late Thursday that it priced a $150 million private convertible senior notes offering, the proceeds of which the New Jersey-based biopharmaceutical company plans to use to fund...To view the full article, register now.
Already a subscriber? Click here to view full article